Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Neurosense Therapeutics Ltd
NRSNCurrent price
1.27 USD
-0.0001 USD (-0.01%)
Last closed
1.25 USD
Company
www.neurosense-tx.com
ISIN
IL0011809592
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
25 157 302 USD
Yield for 12 month
+156.55 %
1Y
3Y
5Y
10Y
15Y
NRSN
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel. Address: Building B, Herzliya, Israel, 4672562
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.25 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-97 000 USD
Last Year
-89 000 USD
Current Quarter
–
Last Quarter
–
Key Figures NRSN
1 year
3 years
5 years
10 years
EBITDA
-11 689 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-150.79 %
PEG Ratio
–
Return On Equity TTM
-494.84 %
Wall Street Target Price
5.25 USD
Revenue TTM
–
Book Value
-0.094 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.65 USD
Diluted Eps TTM
-0.65 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NRSN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NRSN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation NRSN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-1.1574
Price Book MRQ
4.1496
Financials NRSN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NRSN
For 52 weeks
0.42 USD
2.33 USD
50 Day MA
1.1 USD
Shares Short Prior Month
307 426
200 Day MA
1.2 USD
Short Ratio
1.52
Shares Short
235 717
Short Percent
1.41 %
BeatStart